C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
CGSPF Equity

CGSPF

OTCMKTS · CGSPF

Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 3/5
41/100 composite
Fundamentals40
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

Cosmos Holdings currently holds a Neutral rating, supported by a composite score indicating moderate market perception. The analysis places its conviction at an intermediate three out of five, reflecting mid-level confidence. While the rating signifies promise, the pillars exhibit variability in strength. The regulatory framework emerges as notably robust, showing high scores compared to relatively lower contributions from fundamentals, market presence, and editorial coverage.

The company's regulatory environment benefits from a stable posture, with jurisdictional assessments suggesting efforts toward compliance despite recent inactivity in filing. No enforcement actions have been reported, underscoring operational compliance. However, fundamental insights remain elusive due to an absence of public financial disclosures and a lack of market data, which diminishes clarity on revenue growth, profitability margins, and overall financial condition. Editorial coverage has been scant, lacking significant mentions in both newsroom and brief formats over the past reporting periods.

Looking forward, investors should closely monitor regulatory filings as the critical catalyst. The presence and timing of these filings are pivotal in bolstering the regulatory pillar further. Such activity would reinforce the current perceptions of compliance and potentially mitigate any uncertainties associated with fundamental and market data gaps. Thus, observant investors will find any shifts in regulatory cadence a strong indicator of the company's future trajectory.

Scored: 2026-08-25Valid through: 2026-10-09Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Headquarters
141 West Jackson Blvd., Suite 4234 Chicago, IL 60604
Phone
+1 312 536 3102
CEO
Greg Siokas
CFO
George Terzis
Website
Company website
Filings & DisclosuresPrimary sources
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for CGSPF (CGSPF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for CGSPF (CGSPF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Neutral / Wait. Mixed data profile. Await clearer directional signal. (0 bullish signals, 0 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for CGSPF are maintained by Cannabis Investor News and refreshed throughout the trading day.